Wearables and AI poised to reshape clinical trial design, researchers say
Researchers are increasingly using wearable devices—smartwatches, wristbands, patches and rings—to collect real-time physiological data such as heart rate, blood pressure and activity in clinical trials. Specialists say advances in sensor technology and AI could enable decentralized trials where participants are monitored remotely, with dosing personalized to individual data rather than fixed protocols. Current devices already track metrics via accelerometers, gyroscopes and photoplethysmography, with future versions potentially measuring biomarkers like glutamate and cortisol.